Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZD7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,637
Award facts
- Contract value 100% obligated
- $29,637.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,637.36 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen inhalers on December 31, 2025, with a completion date of January 23, 2026. This is a firm fixed-price delivery order issued without a set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System. The product being delivered—Tezspire—is a specialty biologic medication used for treating moderate-to-severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, representing the type of specialized pharmaceutical commodity the company supplies through its federal contracts.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's extensive portfolio of federal awards demonstrates its capability to fulfill competitive federal medical supply procurement across multiple therapeutic domains and order values.
Quick answers
Who was awarded contract SPE2DR26F0ZD7?
SPE2DR26F0ZD7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F0ZD7 worth?
The government has obligated $29,637 on SPE2DR26F0ZD7.
Is contract SPE2DR26F0ZD7 an order under another contract?
Yes. SPE2DR26F0ZD7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZD7 competed?
The extent of competition for SPE2DR26F0ZD7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award